PeptideHelper.org
Your evidence-based peptide reference
Research reference only. Not medical advice. Most compounds are not FDA-approved. Consult a qualified clinician before any human use.

Cognitive Enhancement

Cerebrolysin

FPF-1070

Classification: Neurotrophic peptide mixture (porcine brain)

Mechanism: Mixture of low-MW peptides; neurotrophic factor-like activity on CNS neurons

Benefits: Neurotrophic/neuroprotective; stroke/dementia/TBI benefit in trials (EU/Asia)

Evidence tier: Approved in 50+ countries · Availability: Intl Prescription

Primary sources

  1. Ziganshina LE et al. Cerebrolysin for acute ischaemic stroke. Cochrane Database Syst Rev 2023. PMID 37818733
  2. Rockenstein E et al. Cerebrolysin decreases amyloid-beta production by regulating amyloid protein precursor maturation in a transgenic model of Alzheimer's disease. J Neurosci Res 2006. PMID 16511867

Loading interactive view…